Literature DB >> 2466365

In vivo and in vitro characteristics of contagious ecthyma virus isolates: host response mechanism.

K A Hussain1, D Burger.   

Abstract

Three Vero cell culture-adapted contagious ecthyma virus (CEV) isolates were compared by plaque morphology, ability to induce vesicles in skin and in vivo growth curve characteristics by sampling sequentially experimental skin lesions produced in four sheep and one goat. Two of the isolates (CEV-29A and CEV-378) were from outbreaks of ecthyma in sheep and one (CEV-102) from a human case of orf. When replicating in Vero cells, the viruses exhibited similar growth parameters, but were distinguishable from each other on the basis of plaque morphology. In vivo latent periods for these isolates were 48 h (CEV-29A), 96 h (CEV-102), and 120 h (CEV-378). When isolates CEV-102 and CEV-29A were passaged into another sheep, they produced similar patterns of growth. Isolate CEV-102 produced the highest infectivity titer [1.4 X 10(9) plaque forming units (PFU) g-1], followed by CEV-29A (6.8 X 10(7) PFU g-1) and CEV-378 (2.5 X 10(7) PFU g-1). In addition, these viruses varied in their ability to induce vesicle formation. Virus was no longer detectable at the inoculation sites at 288 h post-infection (PI). We conclude that plaque morphology, ability to induce vesicle formation in the skin and growth curves in the skin can be considered as important criteria to differentiate CEV isolates. A comparison of the growth curves of CEV-378 in the skin of sheep and goats suggested differences in virus-host interaction between the two animal species. Since intravenous injection of 1 X 10(9) PFU of CEV failed to produce lesions in the sham-scarified skin of sheep, virus spread via the hematogenous route from one site to another appears unlikely. No virus-neutralizing antibody or interferons were found in serum samples or in skin homogenates collected between 0 and 24 days PI. Virus-neutralizing antibody was present in the circulation as late as 24 days PI. Lymphocytes collected from CEV-exposed sheep as early as 12 days PI responded specifically to stimulation with CEV antigen. As this was about the time when infectious virus disappeared from the sites, we assume that cell-associated immune mechanisms may play a larger role in virus clearance from skin lesions than virus-neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466365     DOI: 10.1016/0378-1135(89)90088-6

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Viral vascular endothelial growth factor plays a critical role in orf virus infection.

Authors:  L J Savory; S A Stacker; S B Fleming; B E Niven; A A Mercer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice.

Authors:  Timo Fischer; Oliver Planz; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.

Authors:  Ralf Amann; Jörg Rohde; Ulrich Wulle; Douglas Conlee; Rudiger Raue; Olivier Martinon; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

4.  Detection of Orf virus from an outbreak in goats and its genetic relation with other parapoxviruses.

Authors:  B Mondal; A K Bera; M Hosamani; P A Tembhurne; S K Bandyopadhyay
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.816

5.  Recombinant B2L and Kisspeptin-54 DNA Vaccine Induces Immunity Against Orf Virus and Inhibits Spermatogenesis In Rats.

Authors:  Teketay Wassie; Zeng Fanmei; Xunping Jiang; Guiqiong Liu; Shishay Girmay; Zhang Min; Liu Chenhui; Dong Dong Bo; Sohail Ahmed
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

6.  Isolation and phylogenetic analysis of orf virus from the sheep herd outbreak in northeast China.

Authors:  Wei Li; Zhangyong Ning; Wenbo Hao; Deguang Song; Feng Gao; Kui Zhao; Xiaoqing Liao; Ming Li; Daniel L Rock; Shuhong Luo
Journal:  BMC Vet Res       Date:  2012-11-23       Impact factor: 2.741

7.  Orf Virus-Based Vaccine Vector D1701-V Induces Strong CD8+ T Cell Response against the Transgene but Not against ORFV-Derived Epitopes.

Authors:  Alena Reguzova; Michael Ghosh; Melanie Müller; Hanns-Joachim Rziha; Ralf Amann
Journal:  Vaccines (Basel)       Date:  2020-06-10

8.  Genomic Characterization of Orf Virus Strain D1701-V (Parapoxvirus) and Development of Novel Sites for Multiple Transgene Expression.

Authors:  Hanns-Joachim Rziha; Mathias Büttner; Melanie Müller; Ferdinand Salomon; Alena Reguzova; Dominic Laible; Ralf Amann
Journal:  Viruses       Date:  2019-01-30       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.